康泰医学：第四届董事会第二十一次会议决议公告

Core Viewpoint - 康泰医学 announced the approval of extending the authorization period for using temporarily idle raised funds for cash management [2] Group 1 - The fourth meeting of the company's fourth board of directors approved the proposal regarding the extension of the authorization [2]